SlideShare una empresa de Scribd logo
1 de 19
Descargar para leer sin conexión
Disease Classification Category Percent (%)
Acute Condition 34.09%
Acute Injury 23.14%
Chronic 16.18%
Disorders 15.60%
Cardiovascular 8.60%
Pregnancy Related 7.53%
Gynocological 7.45%
Musculoskeletal 6.18%
Mental Health 5.93%
Gastrointestinal 5.60%
Allergy 5.02%
Substance Abuse 4.78%
Other 4.57%
Nervous system 4.53%
Skin related 3.99%
Respiratory 3.91%
Eyes, Ears, Nose & Throat 3.75%
Excretory 3.05%
Personal History 2.22%
Congenital/Hereditary 1.56%
Endocrine 1.56%
Neoplasm 1.32%
Immune System 1.32%
Nutrition 1.19%
Procedure 0.82%
Neuropathy 0.78%
Family History 0.74%
Diabetes 0.62%
.
Table 1. Percent of diseases considered significant in IPV falling into each category (28)
1a Acute Injury
1b Acute Condition
2 Chronic
3 Substance Abuse
4 Mental Health
5 Other
6 Disorders
7 Gynecological
8 Pregnancy Related
9 Allergy
10 Procedure
11 Congenital/Hereditary
12 Nutrition
13 Neoplasm
14 Personal History
15 Family History
16 Neuropathy
17 Diabetes
18 Gastrointestinal
19 Cardiovascular
20 Nervous System
21 Respiratory
22 Musculoskeletal
23 Eyes, Ears, Nose & Throat
24 Excretory
25 Endocrine
26 Immune System
27 Skin Related (not burns)
Figure 1. Network Map of the 28 categories
made up of 2429 symptom terms found to be
significantly more prevalent among victims of
IPV than the general population. Larger nodes
indicate higher coding frequency of the
category by itself, while thicker edges reveal
the strength of relationship between two nodes
by signifying the frequency of any two
categories being coded together on a single
symptom term. Darker nodes appear more
frequently among the pairs than lighter nodes.
1a Acute Injury
1b Acute Condition
2 Chronic
3 Substance Abuse
4 Mental Health
5 Other
6 Disorders
7 Gynecological
8 Pregnancy Related
9 Allergy
10 Procedure
11 Congenital/Hereditary
12 Nutrition
13 Neoplasm
14 Personal History
15 Family History
16 Neuropathy
17 Diabetes
18 Gastrointestinal
19 Cardiovascular
20 Nervous System
21 Respiratory
22 Musculoskeletal
23 Eyes, Ears, Nose & Throat
24 Excretory
25 Endocrine
26 Immune System
27 Skin Related (not burns)
• Out of 2429 symptom terms, there were at
least 208 pairs of interactions present to at
least one of the symptom terms
• Most significant nodes were 1b and 2, having
the great frequency of occurrence
• 1b has the most significant degrees of twelve
• Strong pairings with 2, and 19
• Moderate pairings with 7, 18, 27, 8
• Fair pairings with 3, 20, 21, 22, 23, 24
• 2 has five significant degrees
• Strong pairing with 1b
• Fair pairings with 4, 19, 20, 22
• It is worth noting that pairing between 1b
and 2 could be due to ambiguity of a
symptom term that could be chronic or acute
1a Acute Injury
1b Acute Condition
2 Chronic
3 Substance Abuse
4 Mental Health
5 Other
6 Disorders
7 Gynecological
8 Pregnancy Related
9 Allergy
10 Procedure
11 Congenital/Hereditary
12 Nutrition
13 Neoplasm
14 Personal History
15 Family History
16 Neuropathy
17 Diabetes
18 Gastrointestinal
19 Cardiovascular
20 Nervous System
21 Respiratory
22 Musculoskeletal
23 Eyes, Ears, Nose & Throat
24 Excretory
25 Endocrine
26 Immune System
27 Skin Related (not burns)
• 6 also shows significant pairings, but its
target connected nodes are more significant
in 1b and 2
• Node 1a does have significant symptom
terms associated with it but it doesn’t have
many terms that are associated with another
node
Funding:
• Clinical andTranslational ScienceCollaborative
of Cleveland
• National Center for AdvancingTranslational
Sciences – National Institute of Health
Assistance:
• Explorys Inc.

Más contenido relacionado

Similar a Journal Club 2016 Presentation V3

Vitiligo comorbities by Prof. Michael Tharp
Vitiligo comorbities by Prof. Michael TharpVitiligo comorbities by Prof. Michael Tharp
Vitiligo comorbities by Prof. Michael TharpVR Foundation
 
Emusire presentation
Emusire presentationEmusire presentation
Emusire presentationDoctor Okto
 
Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017
Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017
Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017Ag4HealthNutrition
 
Female infertility,Prof.Salah Roshdy
Female infertility,Prof.Salah RoshdyFemale infertility,Prof.Salah Roshdy
Female infertility,Prof.Salah RoshdySalah Roshdy AHMED
 
Diabetes MELLITUS
Diabetes MELLITUSDiabetes MELLITUS
Diabetes MELLITUSAgasya raj
 
food borne illnesses and its global impact
food borne illnesses and its global impactfood borne illnesses and its global impact
food borne illnesses and its global impactNaimaMukhtar2
 
Celiac disease
Celiac diseaseCeliac disease
Celiac diseasegastrocure
 
Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine Dr. Anees Alyafei
 
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...Evangelos Fragkoulis
 
Ceo (peter nduati) presentation on disease trends
Ceo (peter nduati) presentation on  disease trendsCeo (peter nduati) presentation on  disease trends
Ceo (peter nduati) presentation on disease trendsRayhab Gachango
 
Diabetes mellitus in children; types, pathophysiology and diagnosis
Diabetes mellitus  in children; types, pathophysiology and diagnosisDiabetes mellitus  in children; types, pathophysiology and diagnosis
Diabetes mellitus in children; types, pathophysiology and diagnosisJoyce Mwatonoka
 

Similar a Journal Club 2016 Presentation V3 (20)

Seminar: HOMOEOPATHIC MANAGEMENT OF HIV/AIDS
Seminar: HOMOEOPATHIC MANAGEMENT OF HIV/AIDSSeminar: HOMOEOPATHIC MANAGEMENT OF HIV/AIDS
Seminar: HOMOEOPATHIC MANAGEMENT OF HIV/AIDS
 
Newborn screening kuwait
Newborn screening kuwaitNewborn screening kuwait
Newborn screening kuwait
 
Vitiligo comorbities by Prof. Michael Tharp
Vitiligo comorbities by Prof. Michael TharpVitiligo comorbities by Prof. Michael Tharp
Vitiligo comorbities by Prof. Michael Tharp
 
Emusire presentation
Emusire presentationEmusire presentation
Emusire presentation
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017
Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017
Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017
 
Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017
Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017
Presentation by Paul Torgerson, Food Safety Workshop 24 May 2017
 
Introduction: Richard Smith
Introduction: Richard SmithIntroduction: Richard Smith
Introduction: Richard Smith
 
Female infertility,Prof.Salah Roshdy
Female infertility,Prof.Salah RoshdyFemale infertility,Prof.Salah Roshdy
Female infertility,Prof.Salah Roshdy
 
Diabetes MELLITUS
Diabetes MELLITUSDiabetes MELLITUS
Diabetes MELLITUS
 
Diabetes mellitus
Diabetes mellitus Diabetes mellitus
Diabetes mellitus
 
food borne illnesses and its global impact
food borne illnesses and its global impactfood borne illnesses and its global impact
food borne illnesses and its global impact
 
Near miss
Near missNear miss
Near miss
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine
 
Type 1 diabetes in children
Type 1 diabetes in childrenType 1 diabetes in children
Type 1 diabetes in children
 
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
 
Ceo (peter nduati) presentation on disease trends
Ceo (peter nduati) presentation on  disease trendsCeo (peter nduati) presentation on  disease trends
Ceo (peter nduati) presentation on disease trends
 
Near miss
Near missNear miss
Near miss
 
Diabetes mellitus in children; types, pathophysiology and diagnosis
Diabetes mellitus  in children; types, pathophysiology and diagnosisDiabetes mellitus  in children; types, pathophysiology and diagnosis
Diabetes mellitus in children; types, pathophysiology and diagnosis
 

Journal Club 2016 Presentation V3

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Disease Classification Category Percent (%) Acute Condition 34.09% Acute Injury 23.14% Chronic 16.18% Disorders 15.60% Cardiovascular 8.60% Pregnancy Related 7.53% Gynocological 7.45% Musculoskeletal 6.18% Mental Health 5.93% Gastrointestinal 5.60% Allergy 5.02% Substance Abuse 4.78% Other 4.57% Nervous system 4.53% Skin related 3.99% Respiratory 3.91% Eyes, Ears, Nose & Throat 3.75% Excretory 3.05% Personal History 2.22% Congenital/Hereditary 1.56% Endocrine 1.56% Neoplasm 1.32% Immune System 1.32% Nutrition 1.19% Procedure 0.82% Neuropathy 0.78% Family History 0.74% Diabetes 0.62% . Table 1. Percent of diseases considered significant in IPV falling into each category (28)
  • 7.
  • 8.
  • 9.
  • 10.
  • 11. 1a Acute Injury 1b Acute Condition 2 Chronic 3 Substance Abuse 4 Mental Health 5 Other 6 Disorders 7 Gynecological 8 Pregnancy Related 9 Allergy 10 Procedure 11 Congenital/Hereditary 12 Nutrition 13 Neoplasm 14 Personal History 15 Family History 16 Neuropathy 17 Diabetes 18 Gastrointestinal 19 Cardiovascular 20 Nervous System 21 Respiratory 22 Musculoskeletal 23 Eyes, Ears, Nose & Throat 24 Excretory 25 Endocrine 26 Immune System 27 Skin Related (not burns) Figure 1. Network Map of the 28 categories made up of 2429 symptom terms found to be significantly more prevalent among victims of IPV than the general population. Larger nodes indicate higher coding frequency of the category by itself, while thicker edges reveal the strength of relationship between two nodes by signifying the frequency of any two categories being coded together on a single symptom term. Darker nodes appear more frequently among the pairs than lighter nodes.
  • 12. 1a Acute Injury 1b Acute Condition 2 Chronic 3 Substance Abuse 4 Mental Health 5 Other 6 Disorders 7 Gynecological 8 Pregnancy Related 9 Allergy 10 Procedure 11 Congenital/Hereditary 12 Nutrition 13 Neoplasm 14 Personal History 15 Family History 16 Neuropathy 17 Diabetes 18 Gastrointestinal 19 Cardiovascular 20 Nervous System 21 Respiratory 22 Musculoskeletal 23 Eyes, Ears, Nose & Throat 24 Excretory 25 Endocrine 26 Immune System 27 Skin Related (not burns) • Out of 2429 symptom terms, there were at least 208 pairs of interactions present to at least one of the symptom terms • Most significant nodes were 1b and 2, having the great frequency of occurrence • 1b has the most significant degrees of twelve • Strong pairings with 2, and 19 • Moderate pairings with 7, 18, 27, 8 • Fair pairings with 3, 20, 21, 22, 23, 24 • 2 has five significant degrees • Strong pairing with 1b • Fair pairings with 4, 19, 20, 22 • It is worth noting that pairing between 1b and 2 could be due to ambiguity of a symptom term that could be chronic or acute
  • 13. 1a Acute Injury 1b Acute Condition 2 Chronic 3 Substance Abuse 4 Mental Health 5 Other 6 Disorders 7 Gynecological 8 Pregnancy Related 9 Allergy 10 Procedure 11 Congenital/Hereditary 12 Nutrition 13 Neoplasm 14 Personal History 15 Family History 16 Neuropathy 17 Diabetes 18 Gastrointestinal 19 Cardiovascular 20 Nervous System 21 Respiratory 22 Musculoskeletal 23 Eyes, Ears, Nose & Throat 24 Excretory 25 Endocrine 26 Immune System 27 Skin Related (not burns) • 6 also shows significant pairings, but its target connected nodes are more significant in 1b and 2 • Node 1a does have significant symptom terms associated with it but it doesn’t have many terms that are associated with another node
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19. Funding: • Clinical andTranslational ScienceCollaborative of Cleveland • National Center for AdvancingTranslational Sciences – National Institute of Health Assistance: • Explorys Inc.